Breast diseases

PubMed Free Full Text

Breast cancer treatment: bisphosphonates

Canada

• Breast Cancer Research and Treatment
  • Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey [2021]

• Journal of Bone Oncology
  • Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting [2015]

Canada, United States

• American Society of Clinical Oncology
  • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update [2022]
  • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline [2017]

Europe

• Annals of Oncology
  • Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel [2016]

High-income countries

• Aging
  • Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies [2021]

International

• PLoS ONE
  • The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis [2021]

• Supportive Care in Cancer
  • MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw [2024]

• Therapeutic Advances in Medical Oncology
  • The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis [2019]

Singapore

• Annals Academy of Medicine Singapore
  • Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting [2015]

{Related topics}

• Topic
  • Breast cancer treatment